What does the PaldiSpot test diagnose?
The PaldiSpot test analyses DNA extracted from your patients’ blood and serum to screen more than 20 of the most common strains of Lyme disease (Borrelia, Babesia and Bartonella genospecies).
The PrediSpot test analyses a patients’ DNA to identify inherited genetic traits associated with the development of serious medical conditions, such as Alzheimer’s diseases, coronary artery disease and sudden cardiac death.
Using a highly-sensitive molecular biology technique called quantitative polymerase chain reaction (qPCR), our scientists will analyse DNA extracted from your patients’ blood cells and serum to identify genetic variations called single nucleotide polymorphisms (SNPs) associated with an increased risk of developing life-threatening health conditions.
The PrediSpot test can identify an increased risk of developing various medical issues, including:
The PrediSpot test provides clinicians and patients with essential information to help them make better-informed decisions about future health and wellbeing.
The PrediSpot test is clinically validated and highly accurate. It is suitable for adults aged 18 and over. Results are processed and returned within 14 days.
Clinicians can use the PrediSpot test to identify whether a patient is at an increased risk of developing serious, life-threatening conditions.
During the test, DNA isolated from blood or swab sample is used as a qPCR reaction template. When performing the tests, scientists are searching for specific genetic polymorphisms associated with serious medical conditions.
During the test, we use specific TaqMan Probes for each single nucleotide polymorphism. To ensure accuracy, we perform all reactions in triplicate and conduct positive and negative controls for every strain.
The final report provides detailed information on the patient, including whether they are at increased risk of developing specific medical conditions listed above.
On ordering the PrediSpot test, you will receive a sample collection kit in the mail.
In the box, you will find step-by-step instructions on the sample requirements (blood sample or swab) and details on how to return the sample to us. We have strict internal controls to ensure that we protect all samples throughout the process.
Results of the PrediSpot test are processed and returned within 14 days.
At Biocentaur, we provide ongoing training and support for clinicians on conducting tests and interpreting the results for patients. If you would like more information on the PrediSpot test or any of the Biocentaur range of advanced genetic tests, please visit our FAQs page or contact us.
Download a sample report of our PrediSpot test.
Our PrediSpot test costs £750.